ICU–Acquired Weakness: A Rehabilitation Perspective of Diagnosis, Treatment, and Functional Management

Chest

Volumn 150, Issue 4, 2016, Pages 966-971

  Zorowitz, Richard D ^a  

^a MedStar National Rehabilitation Network   (United States)

Author keywords

critical care; myopathy; neuropathy; rehabilitation

Indexed keywords

CLINICAL FEATURE; ELECTROMYOGRAPHY; GOLD STANDARD; HUMAN; INSULIN TREATMENT; INTENSIVE CARE; INTENSIVE CARE AQUIRED WEAKNESS; LENGTH OF STAY; MUSCLE EXCITATION; MUSCLE STRENGTH; NERVE CONDUCTION; OCCUPATIONAL THERAPY; PATHOGENESIS; PHYSIOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; REHABILITATION CARE; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; TREATMENT OUTCOME; TREATMENT RESPONSE; WEAKNESS; CRITICAL ILLNESS; DAILY LIFE ACTIVITY; HYPERGLYCEMIA; IMMOBILIZATION; INFLAMMATION; INTENSIVE CARE UNIT; LONG TERM CARE; MULTIPLE ORGAN FAILURE; MUSCLE WEAKNESS; MUSCULAR DISEASES; NEUROLOGIC EXAMINATION; POLYNEUROPATHIES; REHABILITATION CENTER; SEPSIS; STATISTICS AND NUMERICAL DATA;

ANTIDIABETIC AGENT; GLUCOCORTICOID; INSULIN; NEUROMUSCULAR BLOCKING AGENT;

ACTIVITIES OF DAILY LIVING; CRITICAL ILLNESS; ELECTROMYOGRAPHY; GLUCOCORTICOIDS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; IMMOBILIZATION; INFLAMMATION; INSULIN; INTENSIVE CARE UNITS; LONG-TERM CARE; MULTIPLE ORGAN FAILURE; MUSCLE WEAKNESS; MUSCULAR DISEASES; NEURAL CONDUCTION; NEUROLOGIC EXAMINATION; NEUROMUSCULAR BLOCKING AGENTS; POLYNEUROPATHIES; REHABILITATION CENTERS; RISK FACTORS; SEPSIS;

EID: 84994525223     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2016.06.006     Document Type: Review

References (48)

1. 1 De Jonghe, B., Sharshar, T., Lefaucheur, J.P., et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 288:22 (2002), 2859–2867.
2. 2 Bednarík, J., Vondracek, P., Dusek, L., Moravcova, E., Cundrle, I., Risk factors for critical illness polyneuromyopathy. J Neurol 252:3 (2005), 343–351.
3. 3 Kress, J.P., Hall, J.B., ICU-acquired weakness and recovery from critical illness. N Engl J Med 370:17 (2014), 1626–1635.
4. 4 Druschky, A., Herkert, M., Radespiel-Troger, M., et al. Critical illness polyneuropathy: clinical findings and cell culture assay of neurotoxicity assessed by a prospective study. Intens Care Med 27:4 (2001), 686–693.
5. 5 Jolley SE, Bunnell A, Hough CL. Intensive care unit acquired weakness [published online ahead of print April 7, 2016]. Chest. http://dx.doi.org/10.1016/j.chest.2016.03.045.
6. 6 Dock, W., The evil sequelae of complete bed rest. JAMA 125:16 (1944), 1083–1085.
7. 7 Herridge, M.S., Cheung, A.M., Tansey, C.M., et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 348:8 (2003), 683–693.
8. 8 Papazian, L., Forel, J.M., Gacouin, A., et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 363:12 (2010), 1107–1116.
9. 9 Griffiths, R.D., Palmer, T.E., Helliwell, T., MacLennan, P., MacMillan, R.R., Effect of passive stretching on the wasting of muscle in the critically ill. Nutrition 11:5 (1995), 428–432.
10. 10 Iwashyna, T.J., Ely, E.W., Smith, D.M., Langa, K.M., Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 304:16 (2010), 1787–1794.
11. 11 van den Berghe, G., Wouters, P., Weekers, F., et al. Intensive insulin therapy in critically ill patients. N Engl J Med 345:19 (2001), 1359–1367.
12. 12 Derde, S., Hermans, G., Derese, I., et al. Muscle atrophy and preferential loss of myosin in prolonged critically ill patients. Crit Care Med 40:1 (2012), 79–89.
13. 13 van den Berghe, G., Schoonheydt, K., Becx, P., Bruyninckx, F., Wouters, P.J., Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 64:8 (2005), 1348–1353.
14. 14 Garnacho-Montero, J., Madrazo-Osuna, J., Garcia-Garmendia, J.L., et al. Critical illness polyneuropathy: risk factors and clinical consequences: a cohort study in septic patients. Intens Care Med 27:8 (2001), 1288–1296.
15. 15 Hermans, G., Wilmer, A., Meersseman, W., et al. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med 175:5 (2007), 480–489.
16. 16 Leatherman, J.W., Fluegel, W.L., David, W.S., Davies, S.F., Iber, C., Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Crit Care Med 153:5 (1996), 1686–1690.
17. 17 Koch, S., Spuler, S., Deja, M., et al. Critical illness myopathy is frequent: accompanying neuropathy protracts ICU discharge. J Neurol Neurosurg Psychiatry 82 (2011), 287–293.
18. 18 Zifko, U.A., Zipko, H.T., Bolton, C.F., Clinical and electrophysiological findings in critical illness polyneuropathy. J Neurol Sci 159:2 (1998), 186–193.
19. 19 de Seze, M., Petit, H., Wiart, L., et al. Critical illness polyneuropathy. A 2-year follow-up study in 19 cases. Eur Neurol 43:2 (2000), 61–69.
20. 20 Douglass, J.A., Tuxen, D.V., Horne, M., et al. Myopathy in severe asthma. Am Rev Respir Dis 146:2 (1992), 517–519.
21. 21 Campellone, J.V., Lacomis, D., Kramer, D.J., Van Cott, A.C., Giuliani, M.J., Acute myopathy after liver transplantation. Neurology 50:1 (1998), 46–53.
22. 22 Blackie, J.D., Gibson, P., Murree-Allen, K., Saul, W.P., Acute myopathy in status asthmaticus. Clin Exp Neurol 30 (1992), 72–81.
23. 23 Griffin, D., Fairman, N., Coursin, D., Rawsthorne, L., Grossman, J.E., Acute myopathy during treatment of status asthmaticus with corticosteroids and steroidal muscle relaxants. Chest 102:2 (1992), 510–514.
24. 24 Lacomis, D., Giuliani, M.J., Van Cott, A., Kramer, D.J., Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects. Ann Neurol 40:4 (1996), 645–654.
25. 25 Sitwell, L.D., Weinshenker, B.G., Monpetit, V., Reid, D., Complete ophthalmoplegia as a complication of acute corticosteroid- and pancuronium-associated myopathy. Neurology 41:6 (1991), 921–922.
26. 26 Shee, C.D., Risk factors for hydrocortisone myopathy in acute severe asthma. Respir Med 84:3 (1990), 229–233.
27. 27 Hermans, G., De Jonghe, B., Bruyninckx, F., Van den Berghe, G., Interventions for preventing critical illness polyneuropathy and critical illness myopathy. Cochrane Database Syst Rev(1), 2014, CD006832.
28. 28 Hermans, G., Wilmer, A., Meersseman, W., et al. Impact of intensive insulin therapy on neuromuscular complications and ventilator-dependency in MICU. Am J Resp Crit Care Med 175:5 (2007), 480–489.
29. 29 Van den Berghe, G., Schoonheydt, K., Becx, P., Bruyninckx, F., Wouters, P.J., Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 64:8 (2005), 1348–1353.
30. 30 Steinberg, K.P., Hudson, L.D., Goodman, R.B., et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 354:16 (2006), 1671–1684.
31. 31 Schweickert, W.D., Pohlman, M.C., Pohlman, A.S., et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 373:9678 (2009), 1874–1882.
32. 32 Routsi, C., Gerovasili, V., Vasileiadis, I., et al. Electrical muscle stimulation prevents critical illness polyneuromyopathy: a randomized parallel intervention trial. Crit Care, 14(2), 2010, R74.
33. 33 Kayambu, G., Boots, R., Paratz, J., Physical therapy for the critically ill in the ICU: a systematic review and meta-analysis. Crit Care Med 41:6 (2013), 1543–1554.
34. 34 Hough, C.L., Lieu, B.K., Caldwell, E.S., Manual muscle strength testing of critically ill patients: feasibility and interobserver agreement. Crit Care, 15(1), 2011, 1.
35. 35 Khan, J., Harrison, T.B., Rich, M.M., Moss, M., Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurology 67:8 (2006), 1421–1425.
36. 36 Lacomis, D., Electrophysiology of neuromuscular disorders in critical illness. Muscle Nerve 47:3 (2013), 452–463.
37. 37 Moss, M., Yang, M., Macht, M., et al. Screening for critical illness polyneuromyopathy with single nerve conduction studies. Intens Care Med 40:5 (2014), 683–690.
38. 38 Herridge, M.S., Tansey, C.M., Matt, A., et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med 364:14 (2011), 1293–1304.
39. 39 Hopkins, R.O., Jackson, J.C., Short- and long-term cognitive outcomes in intensive care unit survivors. Clin Chest Med 30:1 (2009), 143–153.
40. 40 Sacanella, E., Perez-Castejon, J.M., Nicolas, J.M., et al. Functional status and quality of life 12 months after discharge from a medical ICU in healthy elderly patients: a prospective observational study. Crit Care, 15(2), 2011, 1.
41. 41 Desai, S.V., Law, T.J., Needham, D.M., Long-term complications of critical care. Crit Care Med 39:2 (2011), 371–379.
42. 42 Hermans, G., Van Mechelen, H., Bruyninckx, F., et al. Predictive value for weakness and 1-year mortality of screening electrophysiology tests in the ICU. Intens Care Med 41:12 (2015), 2138–2148.
43. 43 Needham, D.M., Mobilizing patients in the intensive care unit: improving neuromuscular weakness and physical function. JAMA 300:14 (2008), 1685–1690.
44. 44 Stiller, K., Phillips, A.C., Lambert, P., The safety of mobilisation and its effects on haemodynamic and respiratory status of intensive care patients. Physiother Theory Pract 20:3 (2004), 175–185.
45. 45 Wells, C., Steinbrenner, G., Beans, J., et al. Severe immobility and malnutrition in post ICU patients requiring prolonged mechanical ventilation: an unmet rehabilitation need. Am J Respir Crit Care Med, 185, 2012, A6852.
46. 46 Jackson, J., Ely, E.W., Morey, M.C., et al. Cognitive and physical rehabilitation of ICU survivors: results of the RETURN randomized, controlled pilot investigation. Crit Care Med 40:4 (2012), 1088–1097.
47. 47 Chen, S., Su, C.L., Wu, Y.T., et al. Physical training is beneficial to functional status and survival in patients with prolonged mechanical ventilation. J Formos Med Assoc 110:9 (2011), 572–579.
48. 48 Unroe, M., Kahn, J.M., Carson, S.S., et al. One-year trajectories of care and resource utilization for recipients of prolonged mechanical ventilation: a cohort study. Ann Intern Med 153:3 (2010), 167–175.